DQ — Deck
Daqo manufactures solar-grade polysilicon at two plants in Xinjiang and Inner Mongolia, China, selling a single commodity product to Chinese wafer makers at spot-market prices with no downstream diversification.
DQ trades below its own cash balance — but the cash may not be yours.
- Negative enterprise value. $1.94B of cash and zero debt against a $1.3B market cap yields an enterprise value of -$640M. Each ADS is backed by $28.70 in cash — 49% above the $19.22 stock price. The market assigns negative value to 305,000 MT of polysilicon capacity.
- Two buyback programs, zero shares bought. The board authorized $100M buyback programs in July 2024 and August 2025. Neither has been executed. Meanwhile, an insider filed a Form 144 in December 2025 to sell 200,000 ADSs. The company sits on $2B with the stock at an all-time-low P/B of 0.29x.
- The VIE wall. Daqo is Cayman-incorporated with operations run through a variable interest entity in Xinjiang. The Xu family — three generations hold board and executive roles — controls the cash. The compensation committee is chaired by a Daqo Group VP who reports to the family. In 2015, the Cayman exemption was used to sell ADSs to the CEO's affiliate without shareholder approval.
Revenue collapsed 86% from peak; the balance sheet is the only thing left standing.
Polysilicon spot prices fell from $35+/kg in 2022 to under $6/kg, dragging gross margins from 74% to negative 21% in two years. Industry nameplate capacity of ~2.2M MT overshoots ~1.5M MT of demand by 40%. Q1 2026 was the worst quarter yet: Daqo produced 43,402 MT but sold only 4,482 MT, choosing to stockpile rather than sell below cost. Revenue hit $26.7M — down 88% sequentially — and the stock dropped 13% on the report.
From cost machine to policy dependent in three years.
The build. From 2013 to 2022, Daqo executed a textbook commodity playbook: relocate to cheap-power Xinjiang, cut cash cost from $14/kg to $4.46/kg across seven expansion phases, and ride the solar supercycle. FY2022 revenue hit $4.6B at 74% gross margins. Net income was $1.8B.
The bust. Industry capacity doubled during the boom. By late 2023, polysilicon prices collapsed 85%. Daqo tripled its own capacity to 305K MT precisely as prices peaked — the Baotou Phase 5 expansion came online into the worst market in company history. First annual loss in FY2024 ($345M), followed by $171M loss in FY2025.
Today. Management's narrative has shifted entirely: from cost reduction and expansion milestones to government anti-involution enforcement and balance-sheet survival. CEO Xiang Xu stated on the Q1 2026 call: "If no policy materializes, company will lower utilization and sell at market pricing." The investment thesis no longer rests on anything Daqo controls.
Three observable signals resolve the debate within 12 months.
- MIIT price enforcement (~June 2026). The Ministry of Industry and Information Technology is expected to publish a cost determination and price floor for polysilicon producers. If binding enforcement follows — fines, license warnings — spot prices could recover from RMB 35-37/kg toward the RMB 45+/kg floor management expects. Without teeth, the guidance gets ignored and DQ keeps burning $70-90M/quarter.
- GCL FBR N-type qualification. GCL Technology's fluidized bed reactor produces granular silicon at $3.72/kg — 17% below Daqo's best quarter. GCL's market share surged from 12% to 26% in 12 months. If a Tier-1 wafer maker like LONGi formally qualifies 100% FBR feedstock for N-type TOPCon without yield penalty, Daqo's cost moat disappears permanently. But GCL carries $1.9B net debt versus Daqo's $2B net cash — it may not survive long enough to capitalize.
- Buyback execution. Any repurchase — even $20-30M — would shatter the trapped-cash thesis. At $19/ADS with $28.70 cash/ADS, non-execution at these levels is maximally damaging to credibility. The Q1 2026 call floated selling Hong Kong-listed shares to fund ADS buybacks, suggesting direct cash movement from the VIE may face practical barriers the $611M FY2022-23 buyback history would not predict.
Lean watchlist — the math is compelling but there is no mechanism to unlock it.
- For: asymmetric payoff. At 305K MT capacity and 57% utilization, each 10 percentage-point recovery adds $150-200M of revenue. A return to $10/kg polysilicon at 70% utilization implies ~$6.65/ADS earnings and a $53 stock at 8x trough P/E — 2.8x from here. Downside is anchored by $28.70 cash/ADS.
- For: last one standing. Daqo's zero-debt, $2B-cash position gives it 6-7 years of runway at minimum utilization. Tongwei carries $18.9B debt, GCL $2.6B, Xinte $6.4B. Organic attrition — forced by the SAMR halt of the $7B capacity fund — destroys leveraged producers first.
- Against: cash is not ADS-holder capital. Two buyback programs, zero execution, one insider sale filing. The Xu family's 30% stake aligns their wealth with the share price but not with minority capital return. The VIE/Cayman structure has never been stress-tested for shareholder protection.
- Against: policy dependence is binary and unpredictable. Every prior Chinese overcapacity cycle (steel, aluminum, cement) took 3-5 years and direct central government mandates to resolve. The draft Price Law is unsigned. The $7B rationalization fund is halted. Management itself admits the thesis depends on enforcement that may never come.
Watchlist to re-rate: Weekly polysilicon spot prices (RMB 35-37/kg currently, need sustained move above RMB 45/kg). Quarterly DQ cash balance trajectory (currently $1.94B, watch for acceleration below $1.5B). Any Form 6-K disclosing actual buyback activity.